6 Biomedical Science colleges beyond the Ivy League in the US that you should check out
Biomedical science stands as a cornerstone of modern healthcare, encompassing disciplines that drive innovations in disease prevention, diagnostics, and treatment. In the United States, pursuing a degree in biomedical sciences opens doors to diverse career paths, including roles in clinical research, biotechnology, pharmaceuticals, and public health.
Graduates often find opportunities in academic institutions, research organizations, healthcare facilities, and private industry.
While Ivy League institutions are renowned for their prestigious programs, numerous non-Ivy League universities across the U.S. offer exceptional biomedical science education. These institutions provide rigorous curricula, state-of-the-art research facilities, and strong industry connections, making them attractive options for prospective students.
Massachusetts Institute of Technology (MIT)
Ranked 2nd globally with an outstanding overall score of 94.7, MIT is a powerhouse in biological sciences. Although widely known for its engineering and technology programs, MIT's Department of Biology and related biomedical research centers have established themselves at the forefront of molecular biology, synthetic biology, and biomedical engineering. Its interdisciplinary approach integrates biology with computational and physical sciences, producing graduates well-prepared for research and innovation in biotechnology, drug development, and healthcare technologies.
University of California, Berkeley (UCB)
UCB holds the 8th position worldwide, earning an overall score of 86.5 in biological sciences. Berkeley offers a broad and flexible biomedical science curriculum through its Department of Molecular and Cell Biology, emphasizing genetic research, cell signaling, and systems biology. The university's strong emphasis on research, coupled with its vibrant biotech ecosystem in the Bay Area, provides students with exceptional opportunities to collaborate on pioneering projects and transition into careers spanning academia, industry, and healthcare sectors.
University of California, San Francisco (UCSF)
UCSF ranks 9th globally in the QS World University Rankings by Subject 2025 for biological sciences, with an impressive overall score of 88.5. Dedicated entirely to health sciences, UCSF is renowned for its leadership in biomedical research, especially in immunology, neuroscience, and cancer biology. Its focused mission and research excellence make it one of the top biomedical science institutions in the country, preparing students for diverse careers in medical research and healthcare innovation.
University of California, Los Angeles (UCLA)
The University of California, Los Angeles holds a global rank of 12th with a score of 86.8 in biological sciences. UCLA's biomedical programs benefit from strong interdisciplinary collaboration through its David Geffen School of Medicine and other research centers. The university offers extensive resources and fosters innovation, making it an attractive destination for students aiming to excel in pharmaceutical research, clinical studies, and public health.
Cornell University
Cornell ranks 14th globally with a score of 84.8, making it another top-tier destination for biomedical science students. Known for combining rigorous academic training with innovative research, Cornell's biomedical programs focus on molecular genetics, physiology, and biomedical engineering. Its unique position bridging the life sciences and engineering fosters interdisciplinary exploration, equipping students with the skills needed for cutting-edge research and careers in biotechnology, pharmaceuticals, and medical device development.
University of Washington, Seattle
At 15th place globally with an overall score of 85.9, the University of Washington is recognized for its comprehensive biomedical programs. Its emphasis on infectious diseases, global health, and translational research reflects a commitment to solving complex health challenges. The university's collaborative environment nurtures research and clinical excellence, providing students with valuable opportunities to engage in impactful biomedical science careers.
Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
22 minutes ago
- India.com
Women with Down Syndrome Show Faster Alzheimer's Progression Than Men, Study Finds
New Delhi: Women with Down syndrome have more advanced signs of Alzheimer's disease than men do, according to research. However, the average age of Down syndrome diagnosis is the same for both men and women, said the University of California, Irvine. The study suggests that women with Down syndrome may carry a higher burden of beta amyloid and phosphorylated tau -- two hallmark Alzheimer's proteins -- than men. It was particularly high in the occipital lobe in women with sporadic Alzheimer's disease -- the more common, late-onset form of Alzheimer's that occurs without a clear genetic cause. This insight points to the need for more sex-specific approaches in both Alzheimer's research and treatment planning, especially in the design of clinical trials. Women versus men "Understanding selective vulnerabilities within the brain and how these differ in women versus men will help us to better navigate treatment outcomes. We're learning the importance of modifiable risk factors, which include accounting for sex-specific risk," said lead author Elizabeth Andrews, doctoral candidate at the varsity. Alzheimer's disease is the primary cause of death for individuals with Down syndrome, who are genetically predisposed to develop the condition earlier in life. While previous studies observed that women with Down syndrome may live longer with dementia than men with Down syndrome, few have looked closely at whether the underlying brain pathology differs by sex. Researchers examined postmortem brain samples In this study, the researchers examined postmortem brain samples and measured levels of beta amyloid and tau. The findings, published in the journal Alzheimer's & Dementia, can shape how we understand and approach treatments for Alzheimer's in this population and beyond. "If women with Down syndrome are further along in disease progression at the time of diagnosis, it could change how we time interventions and interpret outcomes in clinical trials," said Elizabeth Head, Professor of pathology at UC Irvine. "This research could help tailor therapies more effectively, not just for people with Down syndrome, but for the broader Alzheimer's population as well," Head added.
Time of India
2 days ago
- Time of India
6 Biomedical Science colleges beyond the Ivy League in the US that you should check out
Image credit: Pexels Biomedical science stands as a cornerstone of modern healthcare, encompassing disciplines that drive innovations in disease prevention, diagnostics, and treatment. In the United States, pursuing a degree in biomedical sciences opens doors to diverse career paths, including roles in clinical research, biotechnology, pharmaceuticals, and public health. Graduates often find opportunities in academic institutions, research organizations, healthcare facilities, and private industry. While Ivy League institutions are renowned for their prestigious programs, numerous non-Ivy League universities across the U.S. offer exceptional biomedical science education. These institutions provide rigorous curricula, state-of-the-art research facilities, and strong industry connections, making them attractive options for prospective students. Massachusetts Institute of Technology (MIT) Ranked 2nd globally with an outstanding overall score of 94.7, MIT is a powerhouse in biological sciences. Although widely known for its engineering and technology programs, MIT's Department of Biology and related biomedical research centers have established themselves at the forefront of molecular biology, synthetic biology, and biomedical engineering. Its interdisciplinary approach integrates biology with computational and physical sciences, producing graduates well-prepared for research and innovation in biotechnology, drug development, and healthcare technologies. University of California, Berkeley (UCB) UCB holds the 8th position worldwide, earning an overall score of 86.5 in biological sciences. Berkeley offers a broad and flexible biomedical science curriculum through its Department of Molecular and Cell Biology, emphasizing genetic research, cell signaling, and systems biology. The university's strong emphasis on research, coupled with its vibrant biotech ecosystem in the Bay Area, provides students with exceptional opportunities to collaborate on pioneering projects and transition into careers spanning academia, industry, and healthcare sectors. University of California, San Francisco (UCSF) UCSF ranks 9th globally in the QS World University Rankings by Subject 2025 for biological sciences, with an impressive overall score of 88.5. Dedicated entirely to health sciences, UCSF is renowned for its leadership in biomedical research, especially in immunology, neuroscience, and cancer biology. Its focused mission and research excellence make it one of the top biomedical science institutions in the country, preparing students for diverse careers in medical research and healthcare innovation. University of California, Los Angeles (UCLA) The University of California, Los Angeles holds a global rank of 12th with a score of 86.8 in biological sciences. UCLA's biomedical programs benefit from strong interdisciplinary collaboration through its David Geffen School of Medicine and other research centers. The university offers extensive resources and fosters innovation, making it an attractive destination for students aiming to excel in pharmaceutical research, clinical studies, and public health. Cornell University Cornell ranks 14th globally with a score of 84.8, making it another top-tier destination for biomedical science students. Known for combining rigorous academic training with innovative research, Cornell's biomedical programs focus on molecular genetics, physiology, and biomedical engineering. Its unique position bridging the life sciences and engineering fosters interdisciplinary exploration, equipping students with the skills needed for cutting-edge research and careers in biotechnology, pharmaceuticals, and medical device development. University of Washington, Seattle At 15th place globally with an overall score of 85.9, the University of Washington is recognized for its comprehensive biomedical programs. Its emphasis on infectious diseases, global health, and translational research reflects a commitment to solving complex health challenges. The university's collaborative environment nurtures research and clinical excellence, providing students with valuable opportunities to engage in impactful biomedical science careers. Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
&w=3840&q=100)
Business Standard
2 days ago
- Business Standard
Cannabis addiction triples oral cancer risk in just five years, study finds
Cannabis is legal in many parts of the world. But that does not mean it is without risk. A new study titled 'Cannabis use disorder and five-year risk of oral cancer in a multicenter clinical cohort', published in Preventive Medicine Reports, has found that individuals diagnosed with cannabis use disorder (CUD) face more than triple the risk of developing oral cancer, specifically cancers of the lip or tongue, within just five years. Drawing on the medical records of over 45,000 patients from six University of California medical centres, the research raises important concerns about the long-term consequences of heavy and problematic cannabis use. What is cannabis use disorder? Cannabis use disorder (CUD) is a clinical diagnosis for problematic cannabis use that disrupts daily life. It does not just mean occasional recreational smoking, it reflects frequent consumption that can lead to dependence. Previous studies have shown that people smoking about 14 or more joints a week often meet the criteria. In this study, CUD was identified through medical records with formal diagnostic codes, making it a reliable marker for heavy and sustained cannabis exposure. Link between CUD and oral cancer The study followed 45,129 adults who had no oral cancer at the start. Over five years, 949 developed CUD. Of these, 0.74 per cent went on to develop oral cancer, compared to just 0.23 per cent among those without CUD. After adjusting for factors like age, sex, body mass index, and smoking status, CUD patients still had a 3.25 times higher risk of oral cancer. Among smokers, the risk shot up even more, those with both CUD and a smoking history had a six-fold increased risk. How cannabis may raise oral cancer risk Cannabis smoke contains many of the same cancer-causing chemicals as tobacco, polycyclic aromatic hydrocarbons, benzo[a]pyrene, and phenols. These toxins can damage the cells lining the mouth and respiratory tract, causing precancerous changes even without tobacco use. Laboratory studies show cannabis smoke can damage DNA, trigger mutations, and suppress immune defences, especially in tissues directly exposed to the smoke, like the mouth, lips, and lungs. Doctors urge oral checks for cannabis users CUD is on the rise. Yet many heavy users do not see their habit as dangerous, say experts. This study challenges that perception, showing measurable cancer risk over a relatively short period. Researchers of the study warn that CUD may also be linked to other overlapping social and behavioural risk factors, including tobacco use, alcohol consumption, and reduced engagement in preventive healthcare, which can further raise cancer risk.
